Weed (BUDZ) Profit After Tax (2010 - 2026)
Weed's (BUDZ) quarterly Profit After Tax came in at -$175256.0 in Q1 2026, up 60.2% year-on-year from -$109395.9 in Q1 2025, and up 76.68% quarter-over-quarter from -$751375.0 in Q4 2025.
Weed (BUDZ) Profit After Tax (2010 - 2026) Analysis & Trends
Weed's Profit After Tax history runs 13 years deep, the most recent figure standing at -$175256.0 for Q1 2026.
- On a quarterly basis, Profit After Tax rose 60.2% year-over-year to -$175256.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 41.97% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 169.1% from the prior year.
- Profit After Tax grew to -$175256.0 in Q1 2026 per BUDZ's latest filing, from -$751375.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $734248.0 in Q3 2023 and bottomed at -$857202.0 in Q4 2022.
- The 5-year median for Profit After Tax is -$170710.0 (2023), against an average of -$212956.7.
- Across the five-year window, Profit After Tax jumped 338.14% in 2023 and plunged 463.99% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$857202.0 in 2022, then surged by 53.41% to -$399332.0 in 2023, then surged by 66.64% to -$133224.0 in 2024, then plunged by 463.99% to -$751375.0 in 2025, then surged by 76.68% to -$175256.0 in 2026.
- Per Business Quant, the three latest BUDZ Profit After Tax figures stand at -$175256.0 (Q1 2026), -$751375.0 (Q4 2025), and -$73946.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -175,256.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -175,256.00 |
| Dec 31, 2025 | -751,375.00 |
| Sep 30, 2025 | -73,946.00 |
| Jun 30, 2025 | -107,616.00 |
| Mar 31, 2025 | -440,380.00 |
| Dec 31, 2024 | -133,224.00 |
| Sep 30, 2024 | -96,044.00 |
| Jun 30, 2024 | -110,953.00 |
| Mar 31, 2024 | -170,652.00 |
| Dec 31, 2023 | -399,332.00 |
| Sep 30, 2023 | 734,248.00 |
| Jun 30, 2023 | -170,710.00 |
| Mar 31, 2023 | -197,127.00 |
| Dec 31, 2022 | -857,202.00 |
| Sep 30, 2022 | -308,330.00 |
| Jun 30, 2022 | 228,606.00 |
| Mar 31, 2022 | -590,971.00 |
| Dec 31, 2021 | -469,018.00 |
| Sep 30, 2021 | -173,325.00 |
| Jun 30, 2021 | -1.23 Mn |